ClearPoint Neuro CLPT Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$543K-360% | -$80K-125% | $151K+36.0% | ||
| $12.13M+42.9% | $10.41M+34.0% | $8.86M+9.1% | $9.22M+17.3% | $8.49M+11.1% | ||
| $4.37M+30.4% | $4.01M+33.1% | $3.26M-0.4% | $3.66M+27.5% | $3.35M+7.7% | ||
| $7.76M+51.1% | $6.4M+34.5% | $5.6M+15.5% | $5.56M+11.4% | $5.13M+13.4% | ||
| 64%+3.5pp | 61.5%+0.2pp | 63.2%+3.5pp | 60.3%-3.2pp | 60.5%+1.2pp | ||
| $4.52M+33.8% | $3.24M-2.9% | $3.45M+4.1% | $3.83M+22.7% | $3.38M+28.7% | ||
| $5M+22.4% | $5.44M+66.9% | $3.59M+14.2% | $3.39M+22.8% | $4.08M+44.4% | ||
| $6.72M+75.1% | $4.77M+25.4% | $3.84M+8.1% | $4.02M+4.8% | $3.83M+16.5% | ||
| -$8.48M-37.6% | -$7.05M-25.0% | -$5.28M-2.3% | -$5.68M-20.2% | -$6.16M-46.2% | ||
| -69.9%+2.7pp | -67.7%+4.9pp | -59.5%+4.0pp | -61.6%-1.5pp | -72.6%-17.4pp | ||
| $1.38M— | —— | —— | —— | $0-100% | ||
| $351K+132% | —— | —— | —— | $151K-56.5% | ||
| -$35K-975% | -$34K-325% | -$64K-482% | -$52K-1,140% | $4K+115% | ||
| -$9.54M-58.9% | -$7.78M-43.6% | -$5.88M-18.6% | -$5.81M-32.3% | -$6.01M-45.4% | ||
| $8K-55.6% | $4K— | $8K-42.9% | $25K+66.7% | $18K+20.0% | ||
| -$9.55M-58.5% | -$7.79M-44.6% | -$5.89M-18.4% | -$5.84M-32.4% | -$6.03M-45.3% | ||
| -78.8%-7.7pp | -74.8%-5.5pp | -66.5%-5.2pp | -63.3%-7.2pp | -71%-16.7pp | ||
| -$0.32-45.5% | -$0.27-35.0% | -$0.21-16.7% | -$0.21-31.2% | -$0.22-37.5% | ||
| -$0.32-45.5% | -$0.27-35.0% | -$0.21-16.7% | -$0.21-31.2% | -$0.22-37.5% | ||
| 29.5M+6.6% | 28.3M+4.8% | 28.4M+3.0% | 28.3M+2.9% | 27.7M+8.9% | ||
| 29.5M+6.6% | 28.3M+4.8% | 28.4M+3.0% | 28.3M+2.9% | 27.7M+8.9% | ||
| -$35K-975% | -$34K-325% | -$64K-482% | -$52K-1,140% | $4K+115% | ||
| -$8.48M-37.6% | -$7.05M-25.0% | -$5.28M-2.3% | -$5.68M-20.2% | -$6.16M-46.2% | ||
| -$8.39M-38.5% | -$6.8M-25.9% | -$5.21M-6.5% | -$5.28M-17.7% | -$6.06M-52.5% | ||
| -$8.39M-38.5% | -$6.8M-25.9% | -$5.21M-6.5% | -$5.28M-17.7% | -$6.06M-52.5% | ||
| -69.2%+2.2pp | -65.3%+4.2pp | -58.8%+1.5pp | -57.3%-0.2pp | -71.4%-19.4pp | ||
| -$8.48M-37.6% | -$7.05M-25.0% | -$5.28M-2.3% | -$5.68M-20.2% | -$6.16M-46.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is ClearPoint Neuro's revenue?
- ClearPoint Neuro (CLPT) generated $40.6M in revenue over the trailing twelve months, up 26.0% year over year.
- Is ClearPoint Neuro profitable?
- ClearPoint Neuro is not currently profitable: it reported a net loss of $29.1M over the trailing twelve months, a -71.6% net margin.
- What are ClearPoint Neuro's profit margins?
- Gross margin is 62.3% and operating margin is -65.2%, with a -71.6% net margin.
- What is ClearPoint Neuro's earnings per share?
- ClearPoint Neuro's diluted EPS over the trailing twelve months is $-1.01.
- Where does ClearPoint Neuro's income statement data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
